Published in Lancet on July 29, 1978
Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea. Br Med J (1978) 4.99
Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters. Infect Immun (1982) 2.65
In vitro activity of teichomycin and vancomycin alone and in combination with rifampin. Antimicrob Agents Chemother (1983) 2.51
Rapid detection of Clostridium difficile toxin in human feces. J Clin Microbiol (1980) 2.33
Clostridium difficile in gnotobiotic mice. Infect Immun (1980) 2.17
In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis. Antimicrob Agents Chemother (1980) 1.89
Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile. Gut (1986) 1.61
Clostridium difficile infection: guideline-based diagnosis and treatment. Dtsch Arztebl Int (2014) 1.47
Pseudomembranous colitis in a leukaemia unit: a report of five fatal cases. J Clin Pathol (1979) 1.46
Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy. Gut (1983) 1.37
A micro-method for detecting toxins in pseudomembranous colitis. J Clin Pathol (1979) 1.17
Antimicrobial susceptibilities of Clostridium difficile. J Clin Pathol (1980) 1.10
Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection. BMC Infect Dis (2010) 1.04
Treatment of Clostridium difficile-associated disease with teicoplanin. Antimicrob Agents Chemother (1989) 0.92
An epidemic of pseudomembranous colitis: importance of person to person spread. Gut (1987) 0.90
Antibiotic-associated colitis--the continuing saga. Br Med J (Clin Res Ed) (1981) 0.88
Pharmacokinetics of LFF571 and vancomycin in patients with moderate Clostridium difficile infections. Antimicrob Agents Chemother (2014) 0.87
MAPK-activated protein kinase 2 contributes to Clostridium difficile-associated inflammation. Infect Immun (2012) 0.85
Comparison of the in vitro activities of teicoplanin and vancomycin against Clostridium difficile and their interactions with cholestyramine. Antimicrob Agents Chemother (1985) 0.82
Antimicrobial agent-associated colitis and diarrhea. West J Med (1980) 0.81
Clinical update for the diagnosis and treatment of Clostridium difficile infection. World J Gastrointest Pharmacol Ther (2014) 0.81
Pseudomembranous colitis: multiple relapses after treatment with metronidazole. Can Med Assoc J (1981) 0.78
Antibiotic-associated colitis--a bacterial disease. Br Med J (1979) 0.75
Pseudomembranous colitis following cephradine prophylaxis. Postgrad Med J (1982) 0.75
A Prospective Pilot Study on the Systemic Absorption of Oral Vancomycin in Children With Colitis. J Pediatr Pharmacol Ther (2016) 0.75
Recurrent colitis following antibiotic-associated pseudomembranous colitis. Postgrad Med J (1981) 0.75
Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med (1978) 14.65
Tularemia as a biological weapon: medical and public health management. JAMA (2001) 13.23
Botulinum toxin as a biological weapon: medical and public health management. JAMA (2001) 9.18
Susceptibility of anaerobes to cefoxitin and other cephalosporins. Antimicrob Agents Chemother (1975) 8.86
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (2000) 8.45
Anaerobic infections. 1. N Engl J Med (1974) 8.02
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.96
Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis (1977) 7.68
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.06
Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology (1978) 5.91
Comparison of two toxins produced by Clostridium difficile. Infect Immun (1981) 5.16
Glanders in a military research microbiologist. N Engl J Med (2001) 4.77
Clostridium difficile colitis: an efficient clinical approach to diagnosis. Ann Intern Med (1995) 4.42
Cytotoxicity assay in antibiotic-associated colitis. J Infect Dis (1979) 4.39
Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology (1981) 4.04
Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients. Infect Immun (1978) 3.93
Experimental intra-abdominal abscesses in rats: development of an experimental model. Infect Immun (1974) 3.91
Clinical and laboratory observations in Clostridium difficile colitis. Am J Clin Nutr (1980) 3.89
Quantitative bacteriology of the vaginal flora. J Infect Dis (1977) 3.81
Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med (2001) 3.75
Management of anaerobic infections. Ann Intern Med (1975) 3.62
The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J Infect Dis (1977) 3.62
Rapid diagnosis of anaerobic infections by direct gas-liquid chromatography of clinical speciments. J Clin Invest (1976) 3.34
Anaerobic pleuropulmonary infections. Medicine (Baltimore) (1972) 3.30
Microbial synergy in experimental intra-abdominal abscess. Infect Immun (1976) 3.21
Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. Proc Natl Acad Sci U S A (1992) 3.19
Anaerobic infections (second of three parts). N Engl J Med (1974) 3.18
Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med (2001) 3.15
Colitis induced by Clostridium difficile. Rev Infect Dis (1980) 3.15
Anaerobic infections (third of three parts). N Engl J Med (1974) 3.13
Enzyme immunoassays for detection of Clostridium difficile toxins A and B in fecal specimens. J Infect Dis (1984) 3.07
Treatment of anaerobic infections with lincomycin and clindamycin. N Engl J Med (1972) 3.05
Antibiotic-associated pseudomembranous colitis. Rev Infect Dis (1980) 3.02
Cultures for Clostridium difficile in stools containing a cytotoxin neutralized by Clostridium sordellii antitoxin. J Clin Microbiol (1979) 2.86
Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia. Clin Infect Dis (1998) 2.78
Pseudomembranous enterocolitis (antibiotic-related colitis). Adv Intern Med (1977) 2.73
Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis. Blood (2000) 2.64
Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis. Gastroenterology (1980) 2.60
Antimicrobial therapy of experimental intraabdominal sepsis. J Infect Dis (1975) 2.56
Anaerobic infections of the lung and pleural space. Am Rev Respir Dis (1974) 2.46
Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. JAMA (1998) 2.37
Preoperative oral antibiotics reduce septic complications of colon operations: results of prospective, randomized, double-blind clinical study. Ann Surg (1977) 2.36
Experimental intra-abdominal abscesses in rats: quantitative bacteriology of infected animals. Infect Immun (1974) 2.33
Partial purification and characterization of a cytotoxin from Clostridium difficile. Rev Infect Dis (1980) 2.31
Rapid microbiological assay for chloramphenicol and tetracyclines. Antimicrob Agents Chemother (1976) 2.26
Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol (1989) 2.18
Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med (2001) 2.17
Clostridium difficile in gnotobiotic mice. Infect Immun (1980) 2.17
Motivational/solution-focused intervention improves HbA1c in adolescents with Type 1 diabetes: a pilot study. Diabet Med (2003) 2.14
AIDS enteropathy: occult enteric infections and duodenal mucosal alterations in chronic diarrhea. Ann Intern Med (1991) 2.13
Methods for quantitative vaginal flora studies. Am J Obstet Gynecol (1977) 2.05
Serum antibody response to toxins A and B of Clostridium difficile. J Infect Dis (1983) 2.03
Bacteriology of empyema. Lancet (1974) 2.00
Probenecid and zidovudine metabolism. Lancet (1989) 1.99
Protective effect of metronidazole in experimental ulcerative colitis. Gastroenterology (1978) 1.98
Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem (1997) 1.97
Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome. Gastroenterology (1988) 1.93
In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis. Antimicrob Agents Chemother (1980) 1.89
Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Intern Med (2001) 1.89
Is Clostridium difficile endemic in chronic-care facilities? Lancet (1986) 1.88
Anaerobes survive in clinical specimens despite delayed processing. J Clin Microbiol (1976) 1.87
Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1987) 1.82
Update on Department of Health and Human Services guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Hopkins HIV Rep (1999) 1.81
The role of the intestinal microflora in experimental colitis. Am J Clin Nutr (1977) 1.80
Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods (2004) 1.78
Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals. J Clin Microbiol (1984) 1.77
Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology (1989) 1.76
A fiberoptic bronchoscopy technique to obtain uncontaminated lower airway secretions for bacterial culture. Am Rev Respir Dis (1979) 1.76
Bacteriological studies of experimental ulcerative colitis. Am J Clin Nutr (1979) 1.75
Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann Intern Med (1976) 1.73
Cardiothoracic ratio and relative heart volume as predictors of coronary heart disease mortality. The Whitehall study 25 year follow-up. Eur Heart J (1998) 1.72
A study of the self-assembly process in a small spherical virus. Formation of organized structures from protein subunits in vitro. Virology (1967) 1.70
Antimicrobial agents implicated in Clostridium difficile toxin-associated diarrhea of colitis. Johns Hopkins Med J (1981) 1.69
Homologies between gap junction proteins in lens, heart and liver. Nature (1988) 1.69
Practice guidelines for evaluating new fever in critically ill adult patients. Task Force of the Society of Critical Care Medicine and the Infectious Diseases Society of America. Clin Infect Dis (1998) 1.67
Antibiotic-induced lethal enterocolitis in hamsters: studies with eleven agents and evidence to support the pathogenic role of toxin-producing Clostridia. Am J Vet Res (1978) 1.66
A prospective study of rotavirus infection in infants and young children. J Infect Dis (1981) 1.62
The Queenscliff study: a community screening programme for hypertension. Med J Aust (1976) 1.57
Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team. Chest (1998) 1.57
Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med (2001) 1.55
Comparison of five regimens for treatment of experimental clindamycin-associated colitis. J Infect Dis (1978) 1.54
The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia. Chest (1995) 1.53
Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors. J Cell Biol (1998) 1.52
Concepts of fever: recent advances and lingering dogma. Clin Infect Dis (1997) 1.50
The triple threat of aspiration pneumonia. Chest (1975) 1.48
Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data. Pathology (2015) 1.47
Bacteriology and treatment of primary lung abscess. Am Rev Respir Dis (1974) 1.46
Diagnosis of endometriosis by detection of nerve fibres in an endometrial biopsy: a double blind study. Hum Reprod (2009) 1.45
Bacteriology of hospital-acquired pneumonia. Arch Intern Med (1986) 1.45
Bacteriology of expectorated sputum with quantitative culture and wash technique compared to transtracheal aspirates. Am Rev Respir Dis (1978) 1.45
Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis. J Infect Dis (1979) 1.44
Antiendotoxin monoclonal antibodies for gram-negative sepsis: guidelines from the IDSA. Clin Infect Dis (1992) 1.41
Reirradiation for recurrent pterygia. Int J Radiat Oncol Biol Phys (1996) 1.40
Therapeutic efficacy of 29 antimicrobial regimens in experimental intraabdominal sepsis. Rev Infect Dis (1981) 1.40
Cervical and vaginal bacterial flora: ecologic niches in the female lower genital tract. Am J Obstet Gynecol (1978) 1.39
Serum CA-125 levels in women with endometriosis. Aust N Z J Obstet Gynaecol (1989) 1.39
Rectosigmoid cancer after radiotherapy for prostate cancer can be detected early and successfully treated. Australas Radiol (2006) 1.39
Rotavirus infection in adults. Results of a prospective family study. N Engl J Med (1979) 1.39
Septic and technical complications of central venous catheterization. A prospective study of 200 consecutive patients. Ann Surg (1985) 1.39